Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2002
12/18/2002EP1266950A1 Lubricant composition containing a triazine molecular complex compound
12/18/2002EP1266897A2 Hypoglycemic imidazoline compounds
12/18/2002EP1266896A1 Linear ou cyclic ureas, process for their preparation and pharmaceutical compositions containing them
12/18/2002EP1266887A2 Indenoindoline derivatives, their process of preparation and pharmaceutical compositions containing them
12/18/2002EP1266651A2 UV absorbing and photostabilizing agents and compositions and external preparation for skin
12/18/2002EP1265889A1 Medicaments against viral diseases
12/18/2002EP1265888A1 METHOD OF PRODUCING 6-SUBSTITUTED ( i S /i )-NICOTINE DERIVATIVES AND INTERMEDIATE COMPOUNDS
12/18/2002EP1265870A1 New ccr5 modulators: benzimidazoles or benzotriazoles
12/18/2002EP1265864A1 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors
12/18/2002EP1265863A1 Heterocyclic side chain containing metalloprotease inhibitors
12/18/2002EP1265862A2 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/18/2002EP1265850A2 Insecticidal anthranilamides
12/18/2002EP1265641A2 Imaging agents for diagnosis of parkinson's disease
12/18/2002EP1265606A1 Cell adhesion inhibitors
12/18/2002EP1119564B1 Aryl- 4-fluoro-4- (2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl -methanone derivatives as 5-ht1 receptor antagonists
12/18/2002EP1109619B1 Reactor comprising a contact tube bundle
12/18/2002EP0930298B1 Fluorinated 1,4-disubstituted piperidine derivatives
12/18/2002EP0882725B1 Quinolonecarboxylic acid derivatives or salts thereof
12/18/2002EP0882038B1 substituted n-methyl-n-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
12/18/2002EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
12/18/2002CN1096460C Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for treatment of allergic diseases
12/18/2002CN1096459C (R)-5-bromo-N-(1-ethyl-4-methylhexahydro-1H-1, 4-diazepin-6-YL)-2-methoxy-6-methylamino-3-pyridine-carboxamide
12/17/2002US6495699 Antiarthritic agents; osteoporosis
12/17/2002US6495692 Helium-neon excitable reticulocyte dyes derivable from halolepidines
12/17/2002US6495686 Therapy for psychological disorders
12/17/2002US6495684 Inhibit human factor xa; treating diseases characterized by thrombotic activity; for example 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4-(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine
12/17/2002US6495574 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/17/2002US6495573 Non-systemic control of parasites
12/17/2002US6495568 Treatment of tissue ulceration, wound repair and skin diseases
12/17/2002US6495566 Potent antagonists at the strychnine insensitive glycine binding site associated with the n-methylaspartic acid receptor complex
12/17/2002US6495565 For therapy of acute infection, acute phase response, age related macular degeneration, alcoholism, anorexia, asthma, autoimmune disease, autoimmune hepatitis, bechet's disease, cachexia, calcium pyrophosphate dihydrtate deposition
12/17/2002US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth
12/17/2002US6495562 Such as 6-(2-(4,4-diethyl-1-isopropyl-3,4-dihydro-6-isoquinolinyl)cyclopropyl)-2 -naphthalenecarboximidamide
12/17/2002US6495559 For therapy of obesity
12/17/2002US6495550 Substituted benzamido-pyridine derivatives for treatment of disorders mediated by potassium channels
12/17/2002US6495549 1-heteroaryl-piperidine derivatives; moderating neuronal degeneration; promoting neuronal regeneration and outgrowth; treatog neurological disorders arising from neurodegenerative diseases or other disorders involving nerve damage
12/17/2002US6495548 Lactam inhibitors of matrix metalloproteinases, TNF-α and aggrecanase
12/17/2002US6495546 Propanolamine derivatives
12/17/2002US6495542 Such as 2-methoxy-n-(2-methyl-1h-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-5-oxo-1h-1-benzazepin-1-yl)carbonyl-benzam ide; hypertension, heart failure, renal insufficiency, edema, ascites, vasopressin parasecretion syndrome
12/12/2002WO2002099428A1 Luciferin hydrazides
12/12/2002WO2002099424A2 Acridone derivatives as labels for fluorescence detection of target materials
12/12/2002WO2002099388A2 Benzodiazepine bradykinin antagonists
12/12/2002WO2002099097A1 Novel compounds for chemiluminescense procedures
12/12/2002WO2002098873A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002WO2002098872A1 Isoindolines and process for preparation thereof
12/12/2002WO2002098871A1 Phenylcarboxamides and process for preparation thereof
12/12/2002WO2002098869A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds
12/12/2002WO2002098865A2 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors
12/12/2002WO2002098858A1 Integrin antagonists
12/12/2002WO2002098857A1 New indole derivatives with 5-ht6 receptor affinity
12/12/2002WO2002098856A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
12/12/2002WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002WO2002098426A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
12/12/2002WO2002098423A1 S-omeprazole (esomeprazole) inclusion complex with cyclodextrins
12/12/2002WO2002098227A1 Plant growth regulators for cotton hervest
12/12/2002WO2002076977A3 Rho-kinase inhibitors
12/12/2002WO2002076976A3 Rho-kinase inhibitors
12/12/2002WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002WO2002069946A3 Use of triazole compounds for prophylaxis and in therapy for neurodegenerative illnesses, brain traumas and cerebral ischaemia
12/12/2002WO2002066458A3 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
12/12/2002WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002WO2002004424A9 Pyrazole derivatives
12/12/2002US20020188136 Pesticides and herbicides
12/12/2002US20020188129 One pot synthesis of [2, 8-bis (trifluoromethyl)-4- quinolinyl]2-pyridinylmethanone, a mefloquine intermediate
12/12/2002US20020188127 Process for preparing imidazoquinolinamines
12/12/2002US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002US20020188009 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
12/12/2002US20020188008 Novel salt form of pantoprazole
12/12/2002US20020187983 Process for the synthesis of derivatives of 2, 3-dihydro-1, 4-dioxino- [2, 3-f] quinoline
12/12/2002US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002DE10125961A1 Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden Carbazole derivatives and their use for the preparation of a pharmaceutical composition for the treatment of related ailments associated with NPY
12/12/2002CA2754169A1 Acridone derivatives as labels for fluorescence detection of target materials
12/12/2002CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002CA2448824A1 Novel compounds for chemiluminescense procedures
12/12/2002CA2448370A1 Luciferin hydrazides
12/12/2002CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/11/2002WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002EP1264826A1 Novel imidazoline compounds
12/11/2002EP1264820A1 Novel amide compounds
12/11/2002EP1264597A2 Methods and compositions for treating cancer
12/11/2002EP1263760A1 Novel compounds
12/11/2002EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002EP1263754A1 INDALONE AND BENZIMIDAZOLONE INHIBITORS OF FACTOR Xa
12/11/2002EP1263753A1 Imidazol derivatives as raf kinase inhibitors
12/11/2002EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
12/11/2002EP1263734A1 3-thiomethylpyrazoles as pesticides
12/11/2002EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/11/2002EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002EP1263731A1 Method for producing 5-aryl nicotinaldehydes
12/11/2002EP1263729A1 Azacyclic compounds for use in the treatment of serotonin related diseases
12/11/2002EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002EP1263727A1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/11/2002EP1263726A1 N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
12/11/2002EP1263725A1 Novel compounds